Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Selenplus
- Development stage
- Unknown
- Lead developer
- EuRho Vital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Selenplus is a multi-ingredient antioxidant dietary supplement formulated as a capsule. It contains a specific combination of minerals and vitamins, including 50 μg selenium, 8 mg zinc, 400 μg vitamin A, 125 mg vitamin C, and 40 mg vitamin E. The supplement is designed to support the body's antioxidant defense systems by providing essential cofactors for enzymes such as glutathione peroxidase and superoxide dismutase, while also directly scavenging reactive oxygen species. Clinical research has investigated its potential to improve clinical outcomes and antioxidant parameters in patients with inflammatory conditions like rheumatoid arthritis (RA), where it has shown significant improvement in disease activity scores.
- Brand names
- Selenplus
02
Targets
GPX4 (Glutathione peroxidase 4)Misfolded SOD1
Beyond the preview
Go deeper on Selenplus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Selenplus.